Rationale: Several chronic obstructive pulmonary disease (COPD) studies have evaluated risk factors for emergency department (ED) visits or hospitalizations, and found insufficient data available about social and demographic factors that drive these behaviors. This U.S. study was designed to describe the characteristics of COPD patients with ED visits or a hospitalization and to investigate how often common COPD comorbidities are present in these individuals. Methods: Data for 7180 COPD patients regarding demographic factors, comorbidities, smoking status, and ED visits or hospitalization was obtained from the 2012 Behavioral Risk Factor Surveillance System (BRFSS) survey. Logistic regression analysis was used to adjust demographic factors and smoking status to model the correlation between patients with ED visits or hospitalizations and morbidities generating odds ratios (OR) and confidence intervals (CI). Results: Among diagnosed COPD patients in the BRFSS, 16.5% had ED visits or hospitalization in the previous year. These individuals were younger, had a lower socio-economic status (lower education, lower income, and more often unemployed) and 23.4% of the individuals could not visit a doctor because of the financial difficulties compared to 16.7% who had no visit (p<0.0001 for all comparisons). The prevalence of comorbidities was higher in those with ED visits or hospitalization compared to those without.
Introduction
Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity and mortality throughout the world. It is the third leading cause of death in the United States.
1,2 The prevalence of COPD ranges from 8% to 20% worldwide and is the only disease with increasing death rates, rising by 16% since 2002.
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Methods
This study used data collected by the Centers for Disease Control and Prevention (CDC). The Behavioral Risk Factor Surveillance system (BRFSS) survey was conducted in 2012 from 50 states and the District of Columbia and U.S. territories using telephone interviews. Details of the BRFSS and the modules used in the study are found in the online supplement. The core module of the 2012 BRFSS collected information COPD exacerbations impact the natural progression of disease, are responsible for the majority of costs, and are associated with high mortality.
4
COPD patients often need emergency department (ED) visits or hospital admissions because of acute exacerbations that may progress to respiratory failure. Over the past decade, studies have defined the major predictors of exacerbation to be past exacerbations.
5
However, the majority of exacerbations do not present to the ED or to hospitals. It remains unknown how many of these visits also are associated with deterioration of other conditions.
6
Hospitalizations associated with COPD continue to be a significant part of spending of health care resources. In 2010, the health cost associated with COPD in the United States was 50 billion dollars.
4
These costs increase as the severity and exacerbation frequency of COPD becomes worse. The spending associated with hospitalization accounts for more than 70% of COPD-related medical care costs.
7 Minimizing the number of preventable hospitalizations could lead to cost reduction 8,9 and allocation of the resources to preventive care in COPD.
COPD often coexists with other systemic comorbid diseases, such as cardiovascular disease, hypertension, osteoporosis, neuropsychiatric conditions, arthritis, and diabetes mellitus.
10 These comorbidities have shared risk factors with COPD, and can be considered to influence one another and affect mortality.
11 These comorbidities impact patients' health status and interfere with COPD management.
1 However, there is limited population-based epidemiologic data on the COPD patients who use the emergency department or get hospitalized for their disease.
This study was designed to describe the population based on socio-demographic characteristics of the COPD patients with ED visits or hospitalization and to determine their prevalence of common comorbidities. on socio-demographic characteristics (age, sex, race, marital status, height, weight, exercise, disability, and health insurance), and chronic diseases (including myocardial infarction, coronary heart disease/ angina, cancer, stroke, depression, arthritis, kidney disease, and diabetes). Eleven states (Arizona, Connecticut, Illinois, Michigan, Minnesota, Mississippi, Montana, Nevada, Oregon, South Carolina, and Tennessee) elected to collect data on an optional COPD module used for this analysis. We chose to limit the analysis to individuals aged 35 or over to lessen respondents with asthma. Smoking was characterized as a categorical variable for current, past, or never smokers.
A history of COPD was defined as an affirmative response to the following question: "Have you ever been told by your physician that you have chronic obstructive pulmonary disease or COPD, emphysema or chronic bronchitis?" We stratified the characteristics of COPD patients on the basis of the ED visits or hospitalization status over the 1 year prior to the survey from the question: "Have you had to visit an emergency room or be admitted to the hospital in the past 12 months because of your COPD, chronic bronchitis, or emphysema?"
Statistical Analysis
We described the distribution of demographic factors for the patients in the study cohort aged ≥35 years based on ED visits or hospitalization status. First, we tested for unadjusted associations between the variables and the status of ED visits or hospitalization using Chisquare test or t-test, as appropriate. The value p<0.1 was utilized for assessing significance for univariate models and determining potential factors to include in multiple logistic regression where p<0.05 was considered significant. A multinomial logistic regression model then examined the association between the ED visits or hospitalization and individual comorbidities adjusting for demographic factors and smoking status. To facilitate interpretation, the results of the analysis were expressed as an odds ratio (OR) and associated 95% confidence interval (95% CI) for estimation of the prevalence of comorbidities. Statistical analysis was performed using SAS 9.4 package for Windows (SAS Institute Inc., Cary, NC, USA).
Results
Of 90 Figure 1 ). Unexpectedly, the COPD patients who had ED visits or hospitalization were younger (64.6±12.2 years) compared to those without (66.1±11.8 years, p<0.001). This difference was driven by a higher proportion of individuals > age 65 years who did not have an ED visit or hospitalization as depicted in Figure 2 . Although there is a female preponderant response to the BRFSS, there was no significant difference in gender between those with COPD-related ED visits or hospitalization and those without (p=0.49)( Table 1) .
In the analysis comparing race, non-Hispanic whites (80.6%) were the largest number of participants in the study despite oversampling efforts to more closely match the U.S. census by BRFSS methodology. compared to those without. Interestingly, there was no significant difference in ED visits or hospitalization status by smoking category (p=0.1091) ( Table 1) .
Health insurance was present for 91.7% and 92.0% of the cohorts and included prepaid plans such as health maintenance organizations and government plans such as Medicare, Medicaid, or the Indian Health Service. Although the health care coverage was similar, a higher proportion of individuals with ED visits or hospitalization (23.4%) reported that they could not visit a doctor because of financial difficulties compared to those without (16.7%) (p<0.0001). The ED visits or hospitalization rate was higher in western (16.8%) and southern regions (16.6%) of the United States when compared to the northeast region (14.9%) ( Figure  2 ). Further evaluation of disability status revealed that the individuals with ED visits or hospitalization had more disability when compared to those without hospitalization or ED visits (79.0% versus 60.9%, p<0.0001). Figure 3 illustrates that the risk of comorbidities is higher in those who had ED visits or hospitalizations. Differences in the ED visits or hospitalization cohort were also found in low and high body mass index (BMI) categories ( Figure   4 ).
Discussion
Hospital utilization generates the majority of COPDrelated health care expenses.
12 Identifying patients who use the ED or hospital is clinically important, since mortality increases with the frequency of exacerbations.
13 Because most current data about COPD emergency care is derived from single hospital system databases, this population-based study provides a more comprehensive picture of the sociodemographic factors and comorbidities of these COPD patients across the United States.
Most striking were the demographic differences between the emergency care and non-emergency care populations. Although older age is considered a risk factor for hospitalization, 14 our study found that the patients presenting for ED visits or hospitalization were younger. The large power associated with the BRFSS dataset allowed small differences in age to be statistically significant; however, the fact that young individuals make up a significant percentage of this COPD cohort has been shown in other studies.
15-17 Although older individuals may have a higher risk of admission to the hospital, we speculate that younger individuals are more likely to visit an emergency department for less severe exacerbations of symptoms. Unfortunately, the BRFSS does not contain data that could clarify linkages between ED use and hospital admissions.
Gender was not associated with a higher risk for ED visits or hospitalization as has been seen in previous studies 17, 18 Although some studies have found that female sex is a protective factor for ED visits or hospitalization, 15 other studies have found higher ED visits or hospitalization rates.
19 As the difference in tobacco use between sexes continues to narrow 20 and we recognize that women share the burden of smokingrelated disease with men; this finding is not unexpected.
Surprisingly, no differences in tobacco use were found between the cohorts. Tobacco smoking is considered to be one of the most important factors associated with COPD-related hospitalizations, worse outcomes, and comorbid conditions such as cardiovascular disease. As current smoking trends have reduced since 1965, 1 other risk factors such as exposure to air pollution, secondhand smoke, occupational dust, chemicals and hereditary conditions may play an increasingly significant role.
21
Tobacco cessation counseling should be addressed during each encounter with the patient. However, the data suggests that issues related to health care access should transition to a top priority.
Socioeconomic status starting early in life plays an important role affecting the risk of developing COPD independent of smoking and gender.
22 As has been seen in other studies, education, income, and employment were inversely associated with ED visits or hospitalization.
19 Being married was found more often in the cohort without ED visits or hospitalization.
5,23,24 The relationship of socioeconomic status with ED visits or hospitalization is likely complex. Although more smoking, more occupational exposure to dust and fumes, and more secondhand smoke may influence disease pathogenesis, 25,26 less contact with health care, more obesity, and less exercise are demographics that are amenable to interventions.
27
Since we speculate that many of these disparities were associated with ED presentations, alternative interventions to provide social support, improve home environmental triggers of exacerbations, and improve alternative models of health care delivery and medications should be studied.
Interestingly, we found that many of the patients with COPD were not inclined to visit a physician despite having health insurance. Although 91.7% were covered by health insurance, 23.7% could not see a doctor because of the financial difficulties. The impact of high insurance deductibles, residual medical debt, 28 or medication costs on COPD care remain understudied barriers to care. Since regular COPD medication use prevents exacerbations, this finding requires a reassessment of health care delivery in COPD populations.
Low physical activity was found to be an independent risk factor for ED visits or hospitalization. is consistent with other studies. Since pulmonary rehabilitation within 1 month of hospital discharge is associated with less re-hospitalization, 30 there is uncertainty whether the benefits with exercise occur in domains of physiology (improved muscle mitochondrial oxidative capacity and less CO2 production), improved medication compliance, improved mucus clearance, or other factors.
31
In our study, extremes of BMI are associated with higher ED visits or hospitalization. Low BMI was associated with emergency care needs, consistent with other studies. 15, 18, 32, 33 In other studies, a high BMI has been associated with increased risk of death, in part associated with the higher prevalence of comorbidities.
34 This suggests that comorbidities play an important role in the outcome of COPD. Data on the morbidly obese COPD patient is very scarce. Our study suggests that these patients are at the highest risk of ED visits or hospitalization. An observational study from the National Health and Nutritional Examination Survey III reported that these individuals die of unknown respiratory causes.
35 As morbidly obesity increases in prevalence, these individuals with COPD should be studied carefully to better understand this observation.
The group of COPD patients with ED visits or hospitalization had higher proportions of patients with comorbidities compared to those without. Similar to other studies, 36 cardiovascular disease (CVD) was a frequent comorbidity. In a retrospective cohort study, it was found that patients with comorbid COPD and CVD had twice the risk of a COPD-related hospitalization compared to patients without comorbid CVD. shows similar findings and may impact unplanned readmissions. 38 However, the breadth of comorbidity differences between the 2 cohorts is also impressive for disease states that range from cancer to depression.
39
This study cannot define the cause of ED visits or hospitalization. However, a focus on comprehensive care of the chronically-ill COPD patient who presents to emergency care likely will be needed to make an impact on health.
There were some limitations to this study including those associated with the BRFSS survey methodology.
2,40 First, information on symptom severity and pulmonary function testing were not available. Even though we did not have lung function tests, the BRFSS inquires whether lung function testing has been performed. We analyzed the data using only those individuals who had lung function tests finding few differences (data not shown). Second, due to its cross-sectional design, the study shows associations but does not identify causal relationships. The finding that these patients are younger raises the question of whether asthma or an asthma COPD overlap syndrome was present. Table 2 shows that some individuals who were diagnosed with COPD by a physician and eligible for this study, also answered that they had asthma. Third, data regarding the reason for the hospital visit is not available, although the question implies a respiratory cause. However, this deficiency is minor compared to the ability of the BRFSS to provide a population-based snapshot of the emergency care-seeking COPD patient.
Conclusions
In conclusion, the COPD modules of the BRFSS have provided a unique opportunity to characterize the COPD populations using emergency care in the United States. Our study exemplifies current efforts to analyze and report population-based, COPD-related public health data, a major goal of the CDC.
41 COPD patients with lower socio-economic status, extremes of BMI, more disabilities, and frequent comorbidities were independently associated with COPD ED visits or hospitalization. The study also suggests that opportunities to improve health care access, increase pulmonary rehabilitation utilization, and address COPD comorbidities will be needed to better manage COPD patients using emergency services.
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